Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology (Internal Medicine) Physician in Stanford, CA
NPI: 1285791756Primary Practice Location
STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA
Primary Employer
Stanford Hospital
stanfordhealthcare.org
HQ Phone
Get M.D. Robert's Phone Numberphone_androidMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1985 - 2027
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Hematology
Harvard Medical School
hms.harvard.edu
Medical School
Until 1984
Stanford Health Care-Sponsored Stanford University
Fellowship • Neonatal-Perinatal Medicine
1988 - 1989
Fellowship • Hematology
1987 - 1988
Residency • Internal Medicine
1984 - 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 20 | 43 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 18 | 90 |
CD8+CD44hi but not CD4+CD44hi memory T cells mediate potent graft antilymphoma activity without GVHD
Authors: Kornacker, M, Verneris, Mr, Kornacker, B, Ganten, Tm, Scheffold, C, Negrin, Rs
Journal: Cytotherapy
Authors: Xiao, Zunyu, Alam, Israt S, Simonetta, Federico, Chen, Weiyu, Scheller, Lukas, Murty, Surya, Lohmeyer, Juliane K, Ramos, Teresa L, James, Michelle L, Negrin, Robert S, Gambhir, Sanjiv S
Journal: Blood Adv
Lead Sponsor: Regimmune Corporation
Intervention / Treatment: DRUG: Methotrexate, DRUG: sirolimus, PROCEDURE: Allogeneic Bone Marrow Transplantation, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, DRUG: RGI-2001, DRUG: Calcineurin Inhibitors, DRUG: Conditioning Regimen, DRUG: Mofetil Mycophenolate
Lead Sponsor: Everett Meyer
Intervention / Treatment: DRUG: Thymoglobulin, DRUG: Cyclosporine, DRUG: Mycophenolate Mofetil, RADIATION: Total Lymphoid Irradiation (TLI), DRUG: CIK cells
Lead Sponsor: Ronald Levy
Collaborators: National Institutes of Health (NIH)
Intervention / Treatment: DRUG: Rituximab, DRUG: Filgrastim, DRUG: Cyclophosphamide, BIOLOGICAL: PF-3512676, PROCEDURE: Autologous hematopoietic stem cell transplant (HSCT), BIOLOGICAL: CpG-MCL vaccine, PROCEDURE: Vaccine-primed T-cells, DRUG: Standard induction chemotherapy
